CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 9, 2023 · earnings

VTGN earnings: a negative outcome, -6.2%

On November 9, 2023, Vistagen Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.2% in the window around the event. It had already run -8.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$3.08
1d before
$2.89
Event day
$2.57
1d after
$3.18
5d after

Pre-catalyst setup

-8.4%
30-day run-up
8126%
30-day volatility
0.8×
volume spike